AI-generated summary
The authors review clinical use of low-power visible and near infrared light in oncology patients over the past 20 to 25 years, including its use to prevent and manage complications after surgery, chemotherapy and radiotherapy. They report that follow-up of 2 to 4 years did not reveal any increase in tumour recurrence or metastasis. The abstract does not give patient numbers or a formal assessment of the strength of the evidence.
- Who or what was studied
- Patients with oncological diseases treated with low-power visible or near infrared radiation, including those with postoperative, chemotherapy or radiotherapy complications
- Limits stated in the abstract
- The abstract is a narrative review that gives no patient totals, study count, control group details or quantitative results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.